Correlation Between Biophytis and Acer Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biophytis and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biophytis and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biophytis and Acer Therapeutics, you can compare the effects of market volatilities on Biophytis and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biophytis with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biophytis and Acer Therapeutics.
Diversification Opportunities for Biophytis and Acer Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biophytis and Acer is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Biophytis and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Biophytis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biophytis are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Biophytis i.e., Biophytis and Acer Therapeutics go up and down completely randomly.
Pair Corralation between Biophytis and Acer Therapeutics
If you would invest 84.00 in Acer Therapeutics on September 20, 2024 and sell it today you would earn a total of 0.00 from holding Acer Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.78% |
Values | Daily Returns |
Biophytis vs. Acer Therapeutics
Performance |
Timeline |
Biophytis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acer Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biophytis and Acer Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biophytis and Acer Therapeutics
The main advantage of trading using opposite Biophytis and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biophytis position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.Biophytis vs. NRx Pharmaceuticals | Biophytis vs. NRX Pharmaceuticals | Biophytis vs. Akari Therapeutics PLC | Biophytis vs. Armata Pharmaceuticals |
Acer Therapeutics vs. NRx Pharmaceuticals | Acer Therapeutics vs. Pasithea Therapeutics Corp | Acer Therapeutics vs. SAB Biotherapeutics | Acer Therapeutics vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |